Public

The HTA is required to assess the impact of any new regulatory activity or changes to our current activity on our licensed establishments which qualify as ‘businesses’ using an approved methodology. 

We must also publish a summary of new and updated regulatory provisions which fall under the statutory and administrative exemptions annually: these are known as Non-Qualifying Regulatory Provisions (NQRPs) and do not need to be costed.

The Business Impact Target reporting period covered 17 December 2021- 16 December 2022.

We’ve published 6 new inspection reports from establishments in human application, research, and post-mortem sectors.

On inspections we look at compliance with HTA standards including consent, governance and quality systems, traceability, and premises, facilities and equipment. We check whether there are any minor, major or critical shortfalls against these standards.

Read the latest reports:

Today, the Human Tissue Authority (HTA) has published a revised version of Code of Practice F, part two. The HTA undertook a review of the Code to reflect the introduction of deemed consent for deceased organ and tissue donation for the purpose of transplantation in Northern Ireland (NI).